$ARVN
Arvinas Inc Stock $arvn

$arvn Overview Financials Valuation SEC Filings Company Website

2020 Q4 Form 10-K Financial Statement

#000156459021009857 Filed on March 01, 2021

Income Statement

Concept	2020 Q4	2019 Q4	2018
Revenue	$2.220M	$4.893M	$14.30M
YoY Change	-54.63%	42.24%	88.68%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$12.23M	$7.270M	$12.93M
YoY Change	68.23%	24.91%	264.23%
% of Gross Profit
Research & Development	$33.20M	$20.41M	$45.19M
YoY Change	62.63%	40.19%	56.96%
% of Gross Profit
Depreciation & Amortization	$1.060M	$540.0K	$706.0K
YoY Change	96.3%	134.78%	103.23%
% of Gross Profit
Operating Expenses	$45.43M	$27.68M	$58.13M
YoY Change	64.11%	35.81%	79.74%
Operating Profit		-$22.79M	-$43.80M
YoY Change		34.5%	76.9%
Interest Expense	$500.0K	$16.25K	$57.44K
YoY Change	2976.92%	-34.04%	-61.71%
% of Operating Profit
Other Income/Expense, Net	$1.160M	$1.742M	$2.322M
YoY Change	-33.42%	103.59%	318.94%
Pretax Income	-$41.55M	-$21.05M	-$41.48M
YoY Change	97.39%	30.83%	72.47%
Income Tax			$0.00
% Of Pretax Income
Net Earnings	-$41.55M	-$21.05M	-$41.48M
YoY Change	97.41%	30.83%	72.48%
Net Earnings / Revenue	-1871.62%	-430.14%	-290.07%
Basic Earnings Per Share
Diluted Earnings Per Share	-$994.5K	-$583.4K	-$1.328M
COMMON SHARES
Basic Shares Outstanding		33.75M
Diluted Shares Outstanding

Balance Sheet

Concept	2020 Q4	2019 Q4	2018
SHORT-TERM ASSETS
Cash & Short-Term Investments	$688.5M	$280.9M	$187.8M
YoY Change	145.11%	49.57%	379.08%
Cash & Equivalents	$588.4M	$9.211M	$3.200M
Short-Term Investments	$100.2M	$271.7M	$184.6M
Other Short-Term Assets	$6.100M	$3.700M	$2.800M
YoY Change	64.86%	32.14%	833.33%
Inventory
Prepaid Expenses
Receivables	$0.00	$0.00	$2.800M
Other Receivables	$7.400M	$6.281M	$2.200M
Total Short-Term Assets	$703.1M	$290.9M	$195.7M
YoY Change	141.71%	48.65%	198.78%
LONG-TERM ASSETS
Property, Plant & Equipment	$12.30M	$8.455M	$3.600M
YoY Change	45.47%	135.98%	176.92%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$0.00	$0.00
YoY Change
Other Assets	$0.00	$26.76K	$0.00
YoY Change	-100.0%	28.89%
Total Long-Term Assets	$14.30M	$10.76M	$3.600M
YoY Change	32.89%	198.6%	176.92%
TOTAL ASSETS
Total Short-Term Assets	$703.1M	$290.9M	$195.7M
Total Long-Term Assets	$14.30M	$10.76M	$3.600M
Total Assets	$717.4M	$301.6M	$199.3M
YoY Change	137.83%	51.36%	198.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$7.100M	$4.557M	$2.800M
YoY Change	55.81%	65.21%	366.67%
Accrued Expenses	$18.90M	$7.603M	$4.000M
YoY Change	148.59%	90.01%	14.29%
Deferred Revenue	$22.20M	$19.98M
YoY Change	11.11%	24.36%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due		$0.00	$200.0K
YoY Change		-100.0%	0.0%
Total Short-Term Liabilities	$49.20M	$32.81M	$23.00M
YoY Change	49.94%	42.79%	28.49%
LONG-TERM LIABILITIES
Long-Term Debt	$2.000M	$2.000M	$2.000M
YoY Change	0.0%	0.0%	900.0%
Other Long-Term Liabilities	$24.00M	$40.10M	$37.60M
YoY Change	-40.15%	26633.33%	-22.63%
Total Long-Term Liabilities	$2.000M	$2.000M	$39.60M
YoY Change	0.0%	-6.98%	-18.85%
TOTAL LIABILITIES
Total Short-Term Liabilities	$49.20M	$32.81M	$23.00M
Total Long-Term Liabilities	$2.000M	$2.000M	$39.60M
Total Liabilities	$75.20M	$74.96M	$62.60M
YoY Change	0.33%	19.71%	-6.01%
SHAREHOLDERS EQUITY
Retained Earnings	-$491.9M	-$372.6M
YoY Change	32.03%	23.26%
Common Stock	$0.00	$38.46K
YoY Change	-100.0%	23.13%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$642.2M	$226.6M	$136.7M
YoY Change
Total Liabilities & Shareholders Equity	$717.4M	$301.6M	$199.3M
YoY Change	137.83%	51.36%	198.35%

Cashflow Statement

Concept	2020 Q4	2019 Q4	2018
OPERATING ACTIVITIES
Net Income	-$41.55M	-$21.05M	-$41.48M
YoY Change	97.41%	30.83%	72.48%
Depreciation, Depletion And Amortization	$1.060M	$540.0K	$706.0K
YoY Change	96.3%	134.78%	103.23%
Cash From Operating Activities	-$29.02M	-$16.18M	-$16.12M
YoY Change	79.36%	31.97%	-415.22%
INVESTING ACTIVITIES
Capital Expenditures	-$1.860M	-$1.780M	$2.831M
YoY Change	4.49%	187.1%	179.59%
Acquisitions
YoY Change
Other Investing Activities	$58.72M	-$93.64M	-$176.8M
YoY Change	-162.71%	-7.51%	-908.18%
Cash From Investing Activities	$56.86M	-$95.43M	-$179.7M
YoY Change	-159.58%	-6.32%	-960.79%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$114.6M
YoY Change
Debt Paid & Issued, Net			$173.9K
YoY Change			7.76%
Cash From Financing Activities	471.5M	108.7M	168.1M
YoY Change	333.88%	-2.19%	-104250.7%
NET CHANGE
Cash From Operating Activities	-29.02M	-16.18M	-16.12M
Cash From Investing Activities	56.86M	-95.43M	-179.7M
Cash From Financing Activities	471.5M	108.7M	168.1M
Net Change In Cash	499.4M	-2.930M	-27.72M
YoY Change	-17143.69%	-2.98%	-207.35%
FREE CASH FLOW
Cash From Operating Activities	-$29.02M	-$16.18M	-$16.12M
Capital Expenditures	-$1.860M	-$1.780M	$2.831M
Free Cash Flow	-$27.16M	-$14.40M	-$18.95M
YoY Change	88.61%	23.71%	-562.08%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2020	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	us-gaap:AccountingStandardsUpdate201613Member
CY2020Q4	us-gaap	Change In Accounting Principle Accounting Standards Update Adopted ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted	true
CY2020Q4	us-gaap	Change In Accounting Principle Accounting Standards Update Immaterial Effect ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect	true
CY2020	us-gaap	Lessee Operating Lease Existence Of Option To Extend LesseeOperatingLeaseExistenceOfOptionToExtend	true
CY2020	us-gaap	Lessee Operating Lease Existence Of Option To Terminate LesseeOperatingLeaseExistenceOfOptionToTerminate	true
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P4Y
CY2019	arvn	Proceeds From Sale Of Marketable Securities ProceedsFromSaleOfMarketableSecurities	0
CY2018	arvn	Proceeds From Sale Of Marketable Securities ProceedsFromSaleOfMarketableSecurities	0
CY2020Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2020Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2020Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2020	dei	Document Annual Report DocumentAnnualReport	true
CY2020	dei	Document Transition Report DocumentTransitionReport	false
CY2020	dei	Entity File Number EntityFileNumber	001-38672
CY2020	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2020	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-2566120
CY2020	dei	Entity Address Address Line1 EntityAddressAddressLine1	5 Science Park
CY2020	dei	Entity Address Address Line2 EntityAddressAddressLine2	395 Winchester Ave
CY2020	dei	Entity Address City Or Town EntityAddressCityOrTown	New Haven
CY2020	dei	Entity Address State Or Province EntityAddressStateOrProvince	CT
CY2020	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	06511
CY2020	dei	City Area Code CityAreaCode	203
CY2020	dei	Local Phone Number LocalPhoneNumber	535-1456
CY2020	dei	Security12b Title Security12bTitle	Common stock, par value $0.001 per share
CY2020	dei	Trading Symbol TradingSymbol	ARVN
CY2020	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2020	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2020	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2020	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2020Q2	dei	Entity Public Float EntityPublicFloat	1347500000
CY2021Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	48874027
CY2020	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2020	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-118878844
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2278623
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	26757
CY2019Q4	us-gaap	Assets Assets	301641426
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	4556827
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7602904
CY2019Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	19979525
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	673896
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	32813152
CY2019Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	38427882
CY2019Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2000000
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1087422
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1714111
CY2019Q4	us-gaap	Liabilities Liabilities	74955145
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	38461353
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	38461
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-372556846
CY2019Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	599097090
CY2019	us-gaap	Profit Loss ProfitLoss	-70292227
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	107576
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	226686281
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	301641426
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2004561
CY2019	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0
CY2018	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	193779
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0
CY2019	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-24675000
CY2018	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0
CY2018	arvn	Issuance Of Common Stock Underwriters Discounts And Issuance Costs IssuanceOfCommonStockUnderwritersDiscountsAndIssuanceCosts	12048129
CY2019	arvn	Issuance Of Common Stock Underwriters Discounts And Issuance Costs IssuanceOfCommonStockUnderwritersDiscountsAndIssuanceCosts	7497131
CY2020	arvn	Issuance Of Common Stock Underwriters Discounts And Issuance Costs IssuanceOfCommonStockUnderwritersDiscountsAndIssuanceCosts	28099997
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	-61234562
CY2018	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	11630300
CY2018	arvn	Change In Redemption Value Of Redeemable Convertible Preferred Units ChangeInRedemptionValueOfRedeemableConvertiblePreferredUnits	198366756
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-41480466
CY2018	arvn	Issuance Of Common Stock Underwriters Discounts And Issuance Costs IssuanceOfCommonStockUnderwritersDiscountsAndIssuanceCosts	12048129
CY2018	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	111159583
CY2018	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	315166856
CY2018	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-207972
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	136666983
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	20072710
CY2019	arvn	Issuance Of Common Stock Underwriters Discounts And Issuance Costs IssuanceOfCommonStockUnderwritersDiscountsAndIssuanceCosts	7497131
CY2019	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	137088875
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-70292227
CY2019	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2824641
CY2019	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	325299
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	226686281
CY2020	arvn	Issuance Of Common Stock Underwriters Discounts And Issuance Costs IssuanceOfCommonStockUnderwritersDiscountsAndIssuanceCosts	28099997
CY2020	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	431899963
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	30230858
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-119332064
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	8260760
CY2020	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	453220
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	642257512
CY2020	us-gaap	Profit Loss ProfitLoss	-119332064
CY2020	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0
CY2020	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0
CY2019	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0
CY2018	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	193779
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3166139
CY2019	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1561557
CY2018	us-gaap	Depreciation And Amortization DepreciationAndAmortization	706000
CY2020	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-1654516
CY2019	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-154022
CY2018	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-248069
CY2020	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	395070
CY2019	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	0
CY2018	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	0
CY2020	arvn	Operating Lease Right Of Use Asset Amortization OperatingLeaseRightOfUseAssetAmortization	858367
CY2019	arvn	Operating Lease Right Of Use Asset Amortization OperatingLeaseRightOfUseAssetAmortization	691345
CY2018	arvn	Operating Lease Right Of Use Asset Amortization OperatingLeaseRightOfUseAssetAmortization	0
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	30230858
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	20072710
CY2018	us-gaap	Share Based Compensation ShareBasedCompensation	11630300
CY2020	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	1162826
CY2019	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	4024862
CY2018	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	1215514
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1000000
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2775831
CY2018	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-22224169
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2387848
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1065005
CY2018	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2501383
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2042342
CY2019	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1608735
CY2018	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2002163
CY2020	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	10807123
CY2019	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	3601628
CY2018	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	605340
CY2020	arvn	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-920158
CY2019	arvn	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-581961
CY2018	arvn	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	0
CY2020	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-13318313
CY2019	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	4856736
CY2018	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-8548090
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-89756934
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-40626342
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-16117670
CY2020	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	41196166
CY2019	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	256548355
CY2018	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	234894225
CY2020	arvn	Proceeds From Maturities Of Marketable Securities ProceedsFromMaturitiesOfMarketableSecurities	174118543
CY2019	arvn	Proceeds From Maturities Of Marketable Securities ProceedsFromMaturitiesOfMarketableSecurities	169695816
CY2018	arvn	Proceeds From Maturities Of Marketable Securities ProceedsFromMaturitiesOfMarketableSecurities	58059526
CY2020	arvn	Proceeds From Sale Of Marketable Securities ProceedsFromSaleOfMarketableSecurities	37775235
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6447533
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6244024
CY2018	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2830661
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	164250079
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-93096563
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-179665360
CY2020	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0
CY2019	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	169610
CY2018	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	173889
CY2020	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0
CY2019	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0
CY2020	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	27650184
CY2020	arvn	Proceeds From Issuance Of Common Stock In A Public Offering ProceedsFromIssuanceOfCommonStockInAPublicOffering	459999960
CY2019	arvn	Proceeds From Issuance Of Common Stock In A Public Offering ProceedsFromIssuanceOfCommonStockInAPublicOffering	137686006
CY2018	arvn	Proceeds From Issuance Of Common Stock In A Public Offering ProceedsFromIssuanceOfCommonStockInAPublicOffering	114583172
CY2019	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	597131
CY2018	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	3423589
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	8260760
CY2019	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2824641
CY2018	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0
CY2020	us-gaap	Proceeds From Issuance Of Redeemable Convertible Preferred Stock ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock	0
CY2019	us-gaap	Proceeds From Issuance Of Redeemable Convertible Preferred Stock ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock	0
CY2018	us-gaap	Proceeds From Issuance Of Redeemable Convertible Preferred Stock ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock	55000001
CY2020	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0
CY2019	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0
CY2018	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	75000
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	504669030
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	139743906
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	168060695
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	579162175
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	6021001
CY2018	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-27722335
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9211057
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3190056
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	30912391
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	588373232
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9211057
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3190056
CY2020	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	522710
CY2019	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	189908
CY2018	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	159494
CY2020	us-gaap	Interest Paid Net InterestPaidNet	65000
CY2019	us-gaap	Interest Paid Net InterestPaidNet	70420
CY2018	us-gaap	Interest Paid Net InterestPaidNet	39476
CY2020	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	0
CY2019	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	0
CY2018	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	198366756
CY2020	arvn	Number Of Wholly Owned Subsidiaries NumberOfWhollyOwnedSubsidiaries	4
CY2018Q4	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	12000000.0
CY2018Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0
CY2020	us-gaap	Use Of Estimates UseOfEstimates	<p style="margin-bottom:0pt;margin-top:18pt;margin-left:5.67%;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.67%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of the Company’s consolidated financial statements in conformity with U.S. GAAP requires management to make certain estimates and assumptions that affect the reported amounts and disclosures in the financial statements and notes. While management believes that estimates and assumptions used in the preparation of the consolidated financial statements and notes are appropriate, actual results could differ from those estimates. The most significant estimates are those used in determination of the Company’s revenue recognition, research and development expenses, fair value of its common and preferred units, preferred unit warrant liability, incentive equity compensation, and fair value of its investment in a joint venture, Oerth Bio LLC (Oerth). </p>
CY2020Q4	us-gaap	Equity Method Investments EquityMethodInvestments	0
CY2020	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="margin-bottom:0pt;margin-top:18pt;margin-left:5.67%;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Concentration of Credit Risk </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.67%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company maintains its cash in financial institution accounts that, at times during the year, may exceed federally insured limits. The cash balances in the financial institutions are insured by the Federal Deposit Insurance Corporation (FDIC) up to $250,000. Cash may also be maintained at commercial institutions that are not insured by the FDIC. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.67%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For the year ended December 31, 2020, 100% of the Company’s revenue was attributable to three collaborators representing 37%, 32% and 31%, respectively, and one collaborator accounted for the entire accounts receivable balance. For the year ended December 31, 2019, 57% of the Company’s revenue was attributable to a license contributed to Oerth, and two collaborators represented 19% and 16% of total revenue. For the year ended December 31, 2018, two collaborators each represented over 45% of total revenue. </p>
CY2019	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	0
CY2018	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	0
CY2020	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	0
CY2020Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	0
CY2019Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	0
CY2020	arvn	Collaborative Arrangement Payment CollaborativeArrangementPayment	150000
CY2019	arvn	Collaborative Arrangement Payment CollaborativeArrangementPayment	150000
CY2018	arvn	Collaborative Arrangement Payment CollaborativeArrangementPayment	75000
CY2020Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	99596821
CY2020Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	560797
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	100157618
CY2019Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	271553880
CY2019Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	107576
CY2019Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	271661456
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	45089094
CY2019Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	58407407
CY2020	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	18651649
CY2019	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	14335188
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	21800000
CY2020Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	45100000
CY2020Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	19400000
CY2020Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	19200000
CY2020Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	6500000
CY2020Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	45100000
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	11720272
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6132824
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3264861
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12259515
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8455411
CY2020	us-gaap	Depreciation Depreciation	3166139
CY2019	us-gaap	Depreciation Depreciation	1561557
CY2018	us-gaap	Depreciation Depreciation	706000
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	18392339
CY2020	arvn	Lessee Operating Lease Expiration Month And Year LesseeOperatingLeaseExpirationMonthAndYear	2024-09
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y10M24D
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	995228
CY2019	us-gaap	Operating Lease Cost OperatingLeaseCost	817057
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	920158
CY2019	us-gaap	Operating Lease Payments OperatingLeasePayments	581961
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	572413
CY2019	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	571886
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1124684
CY2019	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	100000
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1108065
CY2020Q4	arvn	Lessee Operating Lease Liability Payments Due After Year Two LesseeOperatingLeaseLiabilityPaymentsDueAfterYearTwo	12041
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2244790
CY2020Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1779671
CY2019Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	605246
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	8967126
CY2019Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	5810723
CY2020Q4	arvn	Accrued Research And Development Expense Current AccruedResearchAndDevelopmentExpenseCurrent	8113043
CY2019Q4	arvn	Accrued Research And Development Expense Current AccruedResearchAndDevelopmentExpenseCurrent	1186935
CY2020Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	204529
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	2040261
CY2018	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	606538
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	18859840
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7602904
CY2018Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	7210
CY2019	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	7210
CY2018	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	12359
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	92480
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	377516
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	389970
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	1140034
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	2000000
CY2020	us-gaap	Interest Expense Debt InterestExpenseDebt	65000
CY2019	us-gaap	Interest Expense Debt InterestExpenseDebt	85569
CY2018	us-gaap	Interest Expense Debt InterestExpenseDebt	57440
CY2018Q3	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	3.25
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	30230858
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	20072710
CY2018	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	11630300
CY2020Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions	22647241
CY2020	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1995660
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	357658
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	27.45
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	13.28
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	9.88
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	19400000
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1900000
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.003
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.001
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2018	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.041
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.035
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.025
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.017
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.022
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.033
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.233
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.220
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.203
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.001
CY2018	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	43074539
CY2019Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	21733983
CY2020Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	8978710
CY2019Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	7871790
CY2020Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	10070208
CY2019Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	5121644
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	5038675
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	3580768
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	172170
CY2019Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	183118
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	67334302
CY2019Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	38491303
CY2020Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	43103
CY2019Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	35011
CY2020Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	2377997
CY2019Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	1293932
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	2421100
CY2019Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	1328943
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	64913202
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	37162360
CY2020Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0
CY2019Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0
CY2018	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	1800000
CY2020	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	1400000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-119332064
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-70292227
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-41480466
CY2018	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	198366756
CY2020	arvn	Net Income Loss Available To Common Stockholders Basic And Diluted NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted	-119332064
CY2019	arvn	Net Income Loss Available To Common Stockholders Basic And Diluted NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted	-70292227
CY2018	arvn	Net Income Loss Available To Common Stockholders Basic And Diluted NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted	-239847222
CY2020	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	39534497
CY2019	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	32927697
CY2018	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	9422799
CY2020	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-3.02
CY2019	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-2.13
CY2018	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-25.45
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4693643
CY2019	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4189644
CY2018	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3375313

Files In Submission

Name	View Source	Status
0001564590-21-009857-index-headers.html	Edgar Link	pending
0001564590-21-009857-index.html	Edgar Link	pending
0001564590-21-009857.txt	Edgar Link	pending
0001564590-21-009857-xbrl.zip	Edgar Link	pending
arvn-10k_20201231.htm	Edgar Link	pending
arvn-10k_20201231_htm.xml	Edgar Link	completed
arvn-20201231.xsd	Edgar Link	pending
arvn-20201231_cal.xml	Edgar Link	unprocessable
arvn-20201231_def.xml	Edgar Link	unprocessable
arvn-20201231_lab.xml	Edgar Link	unprocessable
arvn-20201231_pre.xml	Edgar Link	unprocessable
arvn-ex1034_590.htm	Edgar Link	pending
arvn-ex1035_591.htm	Edgar Link	pending
arvn-ex211_11.htm	Edgar Link	pending
arvn-ex231_14.htm	Edgar Link	pending
arvn-ex311_6.htm	Edgar Link	pending
arvn-ex312_15.htm	Edgar Link	pending
arvn-ex321_8.htm	Edgar Link	pending
arvn-ex322_12.htm	Edgar Link	pending
arvn-ex991_751.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
gfbaqn1kfu2x000001.jpg	Edgar Link	pending
gfbaqn1kfu2x000002.jpg	Edgar Link	pending
gfbaqn1kfu2x000003.jpg	Edgar Link	pending
gfbaqn1kfu2x000004.jpg	Edgar Link	pending
gfbaqn1kfu2x000005.jpg	Edgar Link	pending
gfbaqn1kfu2x000006.jpg	Edgar Link	pending
gfbaqn1kfu2x000007.jpg	Edgar Link	pending
gfbaqn1kfu2x000008.jpg	Edgar Link	pending
gfbaqn1kfu2x000009.jpg	Edgar Link	pending
gfbaqn1kfu2x000010.jpg	Edgar Link	pending
gfbaqn1kfu2x000011.jpg	Edgar Link	pending
gfbaqn1kfu2x000012.jpg	Edgar Link	pending
gfbaqn1kfu2x000013.jpg	Edgar Link	pending
gfbaqn1kfu2x000014.jpg	Edgar Link	pending
gxgkxz5ypye4000001.jpg	Edgar Link	pending
gy33ft1zvusk000001.jpg	Edgar Link	pending
gy33ft1zvusk000009.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ARVN
Arvinas Inc Stock $arvn

2020 Q4 Form 10-K Financial Statement

#000156459021009857 Filed on March 01, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ARVN Arvinas Inc Stock $arvn

2020 Q4 Form 10-K Financial Statement

#000156459021009857 Filed on March 01, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ARVN
Arvinas Inc Stock $arvn